Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT00551733

Public ClinicalTrials.gov record NCT00551733. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 30, 2026, 7:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Paclitaxel Poliglumex (CT-2103)/Carboplatin vs Paclitaxel/Carboplatin for the Treatment of Chemotherapy-Naïve Advanced Non-Small Cell Lung Cancer (NSCLC) in Women With Estradiol >30 pg/mL

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy, such as carboplatin, paclitaxel, and paclitaxel poliglumex, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. It is not yet known whether giving carboplatin together with paclitaxel poliglumex is more effective than giving carboplatin together with paclitaxel in treating non-small cell lung cancer. PURPOSE: This randomized phase III trial is studying carboplatin and paclitaxel poliglumex to see how well they work compared with carboplatin and paclitaxel in treating women with stage III, stage IV, or recurrent non-small cell lung cancer.

Study identification

NCT ID
NCT00551733
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
CTI BioPharma
Industry
Enrollment
450 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2007 (Actual)
Primary completion
Dec 25, 2007 (Actual)
Completion
Dec 25, 2007 (Actual)
Last update posted
Oct 5, 2020

2007

United States locations

U.S. sites
41
U.S. states
20
U.S. cities
39
Facility City State ZIP Site status
Scottsdale Medical Specialists Scottsdale Arizona 85258 —
Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center Burbank California 91505 —
Southwest Cancer Care - Escondido Escondido California 92025-4404 —
Clinical Trials and Research Associates, Incorporated Montebello California 90640 —
Stanford Cancer Center Stanford California 94305-5824 —
Broward Oncology Associates Fort Lauderdale Florida 33308-1414 —
Horizon Institute for Clinical Research Hollywood Florida 33021 —
Rush Cancer Institute at Rush University Medical Center Chicago Illinois 60612 —
Joliet Oncology-Hematology Associates, Limited - West Joliet Illinois 60435 —
Hematology Oncology Consultants - Naperville Naperville Illinois 60565 —
Saint James Hospital and Health Centers Comprehensive Cancer Institute - Olympia Fields Olympia Fields Illinois 60461 —
Cancer Center of Indiana New Albany Indiana 47150 —
Providence Medical Group Terre Haute Indiana 47802 —
Family Medicine of Vincennes Clinical Trial Center Vincennes Indiana 47591 —
West Michigan Regional Cancer and Blood Center Free Soil Michigan 49411 —
Newland Medical Associates PC - Southfield Southfield Michigan 48275 —
Hattiesburg Clinic, PA at Forrest General Hattiesburg Mississippi 39401 —
Columbia Comprehensive Cancer Care Clinic Columbia Missouri 65201 —
Kansas City Cancer Centers - South Kansas City Missouri 64131 —
Saint Louis University Cancer Center St Louis Missouri 63110 —
Las Vegas Cancer Center Las Vegas Nevada 89102 —
Veterans Affairs Medical Center - Reno Reno Nevada 89520 —
Richmond University Medical Center Staten Island New York 10310-1699 —
Lincoln Medical and Mental Health Center The Bronx New York 10451 —
New York Medical College Valhalla New York 10595 —
Mid Dakota Clinic, PC Bismarck North Dakota 58501 —
Blood and Cancer Center, Incorporated Canfield Ohio 44406 —
Aultman Cancer Center at Aultman Hospital Canton Ohio 44710-1799 —
Charles M. Barrett Cancer Center at University Hospital Cincinnati Ohio 45219 —
Oklahoma University Cancer Institute Oklahoma City Oklahoma 73104 —
Vita Hematology Oncology at St. Luke's Hospital Bethlehem Pennsylvania 18015 —
Cancer Centers of the Carolinas - Eastside Greenville South Carolina 29615 —
Family Cancer Center, PLLC - Collierville Collierville Tennessee 38077 —
Mid-South Cancer Center Germantown Tennessee 38138 —
Southwest Regional Cancer Center - Central Austin Texas 78705 —
Lone Star Oncology - Austin Austin Texas 78759 —
Mary Crowley Medical Research Center at Sammons Cancer Center Dallas Texas 75246 —
Utah Hematology Oncology, PC Ogden Utah 84403 —
Cancer Outreach Associates - Abingdon Abingdon Virginia 24211 —
Virginia Mason Medical Center Seattle Washington 98101 —
Cell Therapeutics, Incorporated Seattle Washington 98119 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00551733, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 5, 2020 · Synced Sep 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00551733 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →